Conversational agent for healthcare content

1. A method comprising:

at a first device including, a microphone, a display, a processor, a battery and a non-transitory memory:

displaying, on the display, a messaging graphical user interface (GUI) to enable a messaging conversation between a medical representative using the first device and a healthcare provider using a second device, wherein the messaging GUI includes:

a message composition region for composing a message from the medical representative to the healthcare provider,

a send affordance for sending the message to the healthcare provider, and

one or more previous messages that have been sent or received by the first device;

detecting, within the message composition region of the messaging GUI, a value that characterizes a pharmacological characteristic of a pharmaceutical drug or a medical device that is regulated by the Food and Drug Administration (FDA);

obtaining, from a datastore, an FDA-approved value that characterizes the pharmacological characteristic of the pharmaceutical drug or the medical device, wherein the FDA-approved value is extracted from an FDA-approved label for the pharmaceutical drug or the medical device;

prior to sending the message to the healthcare provider, determining whether the value being conveyed in the message satisfies the FDA-approved value; and

in response to determining that the value being conveyed in the message does not satisfy the FDA-approved value, prior to sending the message to the healthcare provider:

displaying, on the display, a breach indicator indicating that the value being conveyed in the message breaches the FDA-approved value;

displaying, on the display, the FDA-approved value;

displaying, on the display, a portion of the FDA-approved label that specifies the FDA-approved value; and

providing an option to modify the value before the message is sent to the healthcare provider.

2. The method of claim 1 , further comprising extracting the FDA-approved value from the FDA-approved label.

3. The method of claim 2 , wherein the FDA-approved label includes structured data that is organized in a defined format that includes a plurality of labels, and wherein extracting the FDA-approved value includes retrieving a value associated with at least one of the plurality of labels.

4. The method of claim 2 , wherein the FDA-approved label includes unstructured data that is not organized in a defined format that includes a plurality of labels; and

wherein extracting the FDA-approved value comprises:

converting the unstructured data into structured data that is organized in the defined format that includes the plurality of labels; and

retrieving a value associated with at least one of the plurality of labels.

5. The method of claim 1 , wherein the FDA-approved value includes a numerical range and the value being conveyed in the message includes a numerical value; and

wherein determining whether the value satisfies the FDA-approved value includes determining whether the numerical value being conveyed in the message is within the numerical range indicated by the FDA-approved value.

6. The method of claim 1 , wherein the FDA-approved value includes a set of one or more phrases and the value being conveyed in the message includes a phrase; and

wherein determining whether the value satisfies the FDA-approved value includes determining whether the phrase being conveyed in the message is within the set of one or more phrases indicated by the FDA-approved value.

7. The method of claim 1 , wherein the value being conveyed in the message is a medical use for the pharmaceutical drug, dosage information for the pharmaceutical drug or a treatment plan that includes administration of the pharmaceutical drug; and

wherein the FDA-approved value includes FDA-approved medical uses for the pharmaceutical drug, FDA-approved dosages for the pharmaceutical drug or FDA-approved treatment plans in which the pharmaceutical drug can be used.

8. The method of claim 1 , wherein the value being conveyed in the message is a medical use for the medical device; and

wherein the FDA-approved value includes FDA-approved medical uses for the medical device.

9. The method of claim 1 , wherein the value being conveyed in the message is a treatment plan that utilizes the pharmaceutical drug or the medical device to treat a medical condition; and

wherein the FDA-approved value includes FDA-approved treatment plans for the medical condition.

10. The method of claim 1 , further comprising:

synthesizing, based on a question and answer model, machine-generated questions and corresponding machine-generated answers from the FDA-approved label.

11. The method of claim 10 , wherein the value being conveyed in the message is an answer to a question that matches one of the machine-generated questions; and

wherein determining whether the value satisfies the FDA-approved value includes determining whether the answer being conveyed by the person matches the corresponding machine-generated answer.

12. The method of claim 1 , wherein the FDA-approved label includes a set of one or more documents.

13. The method of claim 1 , further comprising:

in response to determining that the value being conveyed in the message satisfies the FDA-approved value, displaying, on the display, a satisfaction indicator that indicates that the value satisfies the FDA-approved value.

14. The method of claim 1 , further comprising:

detecting that the message is conveying a second value that characterizes a second pharmacological characteristic of the pharmaceutical drug or the medical device;

in response to the second value satisfying a second FDA-approved value that characterizes the second pharmacological characteristic of the pharmaceutical drug or the medical device:

displaying a satisfaction indicator that indicates that second value satisfies the second FDA-approved value in addition to displaying the breach indicator indicating that the value does not satisfy the FDA-approved value.

15. The method of claim 1 , wherein the breach indicator includes a proposed modification to the value in order to satisfy the FDA-approved value.

16. The method of claim 1 , further comprising:

displaying a score that indicates how often the person provides information that satisfies or breaches FDA-approved values in the FDA-approved label.

17. A non-transitory memory storing one or more programs, which, when executed by one or more processors of a first device, cause the first device to:

display, on a display, a messaging graphical user interface (GUI) to enable a messaging conversation between a medical representative using the first device and a healthcare provider using a second device, wherein the messaging GUI includes:

a message composition region for composing a message from the medical representative to the healthcare provider,

a send affordance for sending the message to the healthcare provider, and

one or more previous messages that have been sent or received by the first device;

detect, within the message composition region of the messaging GUI, a value that characterizes a pharmacological characteristic of a pharmaceutical drug or a medical device that is regulated by the Food and Drug Administration (FDA);

obtain, from a datastore, an FDA-approved value that characterizes the pharmacological characteristic of the pharmaceutical drug or the medical device, wherein the FDA-approved value is extracted from an FDA-approved label for the pharmaceutical drug or the medical device;

prior to sending the message to the healthcare provider, determine whether the value being conveyed in the message satisfies the FDA-approved value; and

in response to determining that the value being conveyed in the message does not satisfy the FDA-approved value, prior to sending the message to the healthcare provider:

display, on the display, a breach indicator indicating that the value being conveyed in the message breaches the FDA-approved value;

display, on the display, the FDA-approved value;

display, on the display, a portion of the FDA-approved label that specifies the FDA-approved value; and

provide an option to modify the value before the message is sent to the healthcare provider.

18. A first device comprising:

one or more processors;

a non-transitory memory;

a microphone;

one or more displays;

a battery; and

one or more programs stored in the non-transitory memory, which, when executed by the one or more processors, cause the first device to:

display, on the one or more displays, a messaging graphical user interface (GUI) to enable a messaging conversation between a medical representative using the first device and a healthcare provider using a second device, wherein the messaging GUI includes:

a message composition region for composing a message from the medical representative to the healthcare provider,

a send affordance for sending the message to the healthcare provider, and

one or more previous messages that have been sent or received by the first device;

detect, within the message composition region of the messaging GUI, a value that characterizes a pharmacological characteristic of a pharmaceutical drug or a medical device that is regulated by the Food and Drug Administration (FDA);

obtain, from a datastore, an FDA-approved value that characterizes the pharmacological characteristic of the pharmaceutical drug or the medical device, wherein the FDA-approved value is extracted from an FDA-approved label for the pharmaceutical drug or the medical device;

prior to sending the message to the healthcare provider, determine whether the value being conveyed in the message satisfies the FDA-approved value; and

in response to determining that the value being conveyed in the message does not satisfy the FDA-approved value, prior to sending the message to the healthcare provider:

display, on the one or more displays, a breach indicator indicating that the value being conveyed in the message breaches the FDA-approved value;

display, on the one or more displays, the FDA-approved value;

display, on the one or more displays, a portion of the FDA-approved label that specifies the FDA-approved value; and

provide an option to modify the value before the message is sent to the healthcare provider.